The Effect of Adding Sodium Bicarbonate 8.4% to Local Anesthesia on Pain During Upper Canine Infiltration
1 other identifier
interventional
30
1 country
1
Brief Summary
The aim of the present study was to evaluate the pain during local anesthetic buccal infiltration for the maxillary canines after adding Sodium Bicarbonate 8.4% during local anesthesia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 14, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2023
CompletedFirst Submitted
Initial submission to the registry
March 1, 2024
CompletedFirst Posted
Study publicly available on registry
March 12, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedMarch 12, 2024
March 1, 2024
8 months
March 1, 2024
March 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain on injection
\- Pain was measured on a visual analogue scale (VAS) starting from 0 which represents (no pain at all) and ending with 10 which represents (the most severe pain)
one week
Study Arms (2)
Buffered LA
ACTIVE COMPARATORAA buffered 2% lidocaine with 1:80000 epinephrine and sodium bicarbonate 8.4% was used for one site
Unbuffered LA
ACTIVE COMPARATORan unbuffered 2% lidocaine with 1: 80000 epinephrine for the other site at the same appointment.
Interventions
A buffered 2% lidocaine with 1:80000 epinephrine and sodium bicarbonate 8.4% was used for one site
an unbuffered 2% lidocaine with 1: 80000 epinephrine for the other site at the same appointment.
Eligibility Criteria
You may qualify if:
- Caries free with no restorations, periapical lesions, or history of trauma at the site of injection.
- Willingness to participate in the study and ability to describe and evaluate their pain.
- No painkillers, or sedatives taken for at least 24 hours so that pain assessment isn't affected.
You may not qualify if:
- allergy to local anesthetics.
- pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Al Wataniya Private University
Hama, Hama Government, 00000, Syria
Study Officials
- PRINCIPAL INVESTIGATOR
Tarek A Agwa, Senior Lect
Al Wataniya Private University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior lecturer
Study Record Dates
First Submitted
March 1, 2024
First Posted
March 12, 2024
Study Start
January 14, 2023
Primary Completion
September 10, 2023
Study Completion
June 30, 2024
Last Updated
March 12, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share